I obtained my Doctor of Medicine (MD) degree from the National University of Buenos Aires in 2007. I completed my residency in adult neurology at Ramos Mejía Hospital in Buenos Aires (2007–2011), where Ideveloped an early interest in neuromuscular disorders. I then undertook a clinical fellowship in adult neuromuscular disorders at Hospital Italiano de Buenos Aires (2011–2012), focusing on diagnosis and management of hereditary and acquired muscle and nerve diseases.
In parallel with my clinical practice as an adult neurologist at FLENI Hospital (2012–2014), I pursued additional specialisation in neuromuscular neuropathology and paediatric Neuromuscular disorders, gaining in-depth expertise in muscle and nerve biopsy interpretation at the Garrahan Hospital. In 2014, I transitioned to paediatric neurology and joined The Hospital for Sick Children (SickKids) in Toronto as a Clinical and Research Fellow in Pediatric Neuromuscular Medicine, completing formal training in pediatric EMG and complex neuromuscular syndromes.
Since 2019, I have served as a Staff Neurologist at SickKids and as Director of the Neuromuscular Fellowship programme, while holding faculty appointments at the University of Toronto, first as Assistant Professor and currently as Associate Professor.
Career summary
I am a paediatric neurologist and Associate Professor at the University of Toronto with a subspecialty focus in neuromuscular disorders. I earned my MD in Buenos Aires in 2007, completed residency in adult neurology, and pursued a clinical fellowship in adult neuromuscular medicine at Hospital Italiano. While serving as a staff neurologist at FLENI Hospital, I also trained in neuromuscular neuropathology.
In 2014, I joined The Hospital for Sick Children (SickKids) as a Clinical and Research Fellow in Paediatric Neuromuscular Medicine. I was appointed Staff Neurologist in 2019 and currently serve as Director of the Neuromuscular Programme. In this role, I have led major advancements in clinical care, including the implementation of gene therapy for spinal muscular atrophy (SMA) in a hospital-based setting—making SickKids the first centre in Canada to deliver this treatment.
I chaired the Royal College AFC Committee for Neuromuscular Medicine from its inception until 2024 and am currently a member of the Education Committee of the World Muscle Society. I developed and lead a nationally recognised paediatric neuromuscular fellowship programme and spearheaded a 42-week national curriculum to standardise neuromuscular training across Canada.
I am the Principal or Co-Investigator on multiple CIHR- and MDC-funded clinical trials. In 2023, I received the Department of Paediatrics Award for Outstanding Clinical Contribution due to my contribution on neuromuscular care at the Hospital for Sick Children.
What is the personal or professional achievement you’re most proud of?
The personal and professional achievement I am most proud of is leading the development of comprehensive education in neuromuscular disorders, with a strong emphasis on emerging gene therapies. I have worked to create structured training programmes for medical students, residents, fellows, and colleagues, ensuring that both the fundamentals of neuromuscular disease and the rapidly evolving field of genetic therapeutics are taught in a clinically relevant and accessible way. This educational effort has gone hand-in-hand with introducing gene therapy into our hospital’s clinical practice—building the infrastructure, multidisciplinary collaborations, and protocols needed to safely and equitably offer these treatments. By integrating education and clinical innovation, our institution has become a leader in training and in delivering cutting-edge care for patients with neuromuscular disorders.
Why did you first join the WMS?
I joined the World Muscle Society (WMS) in 2014 because it provides a unique platform for networking with colleagues worldwide who are advancing care and research in neuromuscular disorders. Attending the annual Congresses is particularly valuable, not only for staying up to date with the latest scientific and clinical developments, but most importantly for the opportunity to connect with experts, exchange ideas, and learn firsthand what other leading centres are doing. For me, the WMS is less about passive knowledge acquisition and more about building meaningful collaborations that strengthen both research and patient care.
What is your goal in joining the Executive Board?
My goal in joining the Executive Board is to contribute meaningfully to global neuromuscular education by promoting equitable access to high-quality training across regions. Throughout my career, I have been particularly committed to strengthening educational frameworks and reducing geographic disparities in specialised knowledge. As Chair of the Royal College AFC Committee and a member of the World Muscle Society Education Committee, I have worked to develop standardised curricula, support international collaboration, and create learning pathways that empower clinicians in under-resourced settings.
I believe the Executive Board provides a critical platform to expand these efforts, advocate for inclusive educational policies, and support initiatives that ensure learners worldwide—regardless of location—have the tools and mentorship they need to deliver excellent neuromuscular care.
